Education
About Us
Working with TipRanks
Follow Us
Innocan Pharma Corporation (INNPF)
OTHER OTC:INNPF
INNPF Stock Chart & Stats
$12.04
<$0.01(0.06%)
At close: 4:00 PM EST
$12.04
<$0.01(0.06%)
Day’s Range― - ―
52-Week Range$4.66 - $14.90
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.00
Market Cap
$21.02M
Enterprise Value$17.07M
Total Cash (Recent Filing)$10.22M
Total Debt (Recent Filing)$2.12M
Price to Earnings (P/E)―
Beta-0.11
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding4,498,772
10 Day Avg. Volume0
30 Day Avg. Volume13
Financial Highlights & Ratios
PEG Ratio0.34
Price to Book (P/B)7.71
Price to Sales (P/S)1.35
P/FCF Ratio-25.00
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue0.58
Enterprise Value/Gross Profit0.65
Enterprise Value/Ebitda-8.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
InnoCan Pharma News
INNPF FAQ
What was Innocan Pharma Corporation’s price range in the past 12 months?
Innocan Pharma Corporation lowest stock price was $4.66 and its highest was $14.90 in the past 12 months.
What is Innocan Pharma Corporation’s market cap?
Innocan Pharma Corporation’s market cap is $21.02M.
When is Innocan Pharma Corporation’s upcoming earnings report date?
Innocan Pharma Corporation’s upcoming earnings report date is Mar 26, 2026 which is in 41 days.
How were Innocan Pharma Corporation’s earnings last quarter?
Innocan Pharma Corporation released its earnings results on Nov 26, 2025. The company reported -$0.432 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.432.
Is Innocan Pharma Corporation overvalued?
According to Wall Street analysts Innocan Pharma Corporation’s price is currently Overvalued.
Does Innocan Pharma Corporation pay dividends?
Innocan Pharma Corporation does not currently pay dividends.
What is Innocan Pharma Corporation’s EPS estimate?
Innocan Pharma Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innocan Pharma Corporation have?
Innocan Pharma Corporation has 4,498,772 shares outstanding.
What happened to Innocan Pharma Corporation’s price movement after its last earnings report?
Innocan Pharma Corporation reported an EPS of -$0.432 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Innocan Pharma Corporation?
Currently, no hedge funds are holding shares in INNPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Innocan Pharma Corporation
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
INNPF Earnings Call
Q3 2025
0:00 / 0:00
Technical Analysis
Willow Biosciences Inc
―
Quantum Biopharma
―
MediPharm Labs
―
Voyageur Pharmaceuticals
―
Avicanna
―